Empery's stake is flat and passive — no signal of increased conviction or activist intent. Monitor for any future conversion to SC 13D, which would indicate a shift to activist strategy.
Price Chart
Executive Summary
Empery Asset Management filed an amended Schedule 13G disclosing a passive 4.99% beneficial ownership stake in Lantern Pharma as of September 30, 2026. The stake includes 755,891 shares (543,337 common shares plus 212,554 shares issuable upon exercise of warrants), representing no change from the prior filing 70 days ago. The filing confirms Empery remains a passive holder below the 5% threshold with no activist intent.
Key Financial Metrics
Key Facts
- Empery Asset Management reports 4.99% beneficial ownership in Lantern Pharma as of September 30, 2026
- Total position: 755,891 shares (543,337 common shares + 212,554 warrant shares)
- Warrants are subject to a 4.99% blocker preventing exercise above that threshold
- Stake unchanged from prior SC 13G/A filed August 4, 2026
- Filing confirms passive intent under Rule 13d-1(b) — no activist conversion expected
Financial Impact
No material financial impact — passive stake unchanged at 4.99%
Risk Factors
- Warrant blocker at 4.99% limits Empery's ability to increase stake via warrant exercise without SEC filing change
- Passive 13G status could convert to activist 13D if Empery engages management
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0000919574-26-006874 |
| Document: 0000919574-26-006874-index.html | 0000919574-26-006874 |
| Document: 0000919574-26-006874.txt | 0000919574-26-006874 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 7d ago | DEF 14A | $0.6564 | awaiting T+60 | — | $0.6240 (+4.94%) |
Oct 13, 2026 13d ago | SC 13G/A | $0.7107 | awaiting T+60 | — | $0.6240 (−12.20%) |
Oct 1, 2026 25d ago | 8-K | $0.8601 | awaiting T+60 | — | $0.6240 (+27.45%) |
Sep 30, 2026 26d ago | 8-K | $1.00 | awaiting T+60 | — | $0.6240 (+37.60%) |
Sep 30, 2026 26d ago | 424B5 | $1.01 | awaiting T+60 | — | $0.6240 (+38.22%) |
Sep 23, 2026 4w ago | 8-K | $1.21 | awaiting T+60 | — | $0.6240 (−48.43%) |
Sep 23, 2026 4w ago | 8-K | $1.39 | awaiting T+60 | — | $0.6240 (−55.11%) |
Aug 14, 2026 10w ago | 8-K | $2.65 | awaiting T+60 | — | $0.6240 (−76.45%) |
Jun 22, 2026 18w ago | EFFECT | $3.88 $1.70 | ▲ +56.19% | ▲ +57.93% | $0.6240 (+83.92%) |
May 15, 2026 23w ago | 8-K | $3.00 $2.66 | ▼ −11.33% | ▼ −16.18% | $0.6240 (−79.20%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers